Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 14, 2004
Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement
Lawrence H Einhorn, Bernardo Rapoport, Jim Koeller, et al.
Fertility and Sterility
|
December 20, 2005
Management of patients receiving long-term treatment with mifepristone
Irving M Spitz, Steven M Grunberg, Nathalie Chabbert-Buffet, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 28, 2008
Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy
Steven M Grunberg, Matthew Dugan, Hyman Muss, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2012
Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives
John M Salsman, Steven M Grunberg, Jennifer L Beaumont, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 26, 2010
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art
Steven M Grunberg, David Warr, Richard J Gralla, et al.
Cancer Investigation
|
December 13, 2006
Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma
Steven M Grunberg, Martin H Weiss, Christy A Russell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 16, 2004
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update
Steven M Grunberg, David Osoba, Paul J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 1, 2015
Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)
Meinolf Karthaus, Csőszi Tibor, Vito Lorusso, et al.
The Lancet. Oncology
|
May 12, 2009
Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial
Steven M Grunberg, Janusz Rolski, Janos Strausz, et al.
The Journal of Supportive Oncology
|
January 27, 2011
Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients
Elenir B C Avritscher, Ya-Chen T Shih, Charlotte C Sun, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 14, 2004
Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement
Lawrence H Einhorn, Bernardo Rapoport, Jim Koeller, et al.
Fertility and Sterility
|
December 20, 2005
Management of patients receiving long-term treatment with mifepristone
Irving M Spitz, Steven M Grunberg, Nathalie Chabbert-Buffet, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 28, 2008
Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy
Steven M Grunberg, Matthew Dugan, Hyman Muss, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 7, 2012
Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives
John M Salsman, Steven M Grunberg, Jennifer L Beaumont, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 26, 2010
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art
Steven M Grunberg, David Warr, Richard J Gralla, et al.
Cancer Investigation
|
December 13, 2006
Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma
Steven M Grunberg, Martin H Weiss, Christy A Russell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 16, 2004
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update
Steven M Grunberg, David Osoba, Paul J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 1, 2015
Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)
Meinolf Karthaus, Csőszi Tibor, Vito Lorusso, et al.
The Lancet. Oncology
|
May 12, 2009
Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial
Steven M Grunberg, Janusz Rolski, Janos Strausz, et al.
The Journal of Supportive Oncology
|
January 27, 2011
Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients
Elenir B C Avritscher, Ya-Chen T Shih, Charlotte C Sun, et al.
Page
of 5